CONTACT US
CONTACT US

February 18, 2019

Autologous mesenchymal stem cell application for cartilage defect in recurrent patellar dislocation: A case report

Introduction

Recurrent patellar dislocation is characterized by repeated episodes of knee cap displacement, often resulting in cartilage lesions and chronic symptoms. Traditional management approaches often yield limited success, necessitating innovative treatments such as mesenchymal stem cell (MSC) therapy.

Case Presentation

Patient History and Examination

A 21-year-old male presented with left knee discomfort following recurrent patellar dislocations over ten years. Physical examination revealed anterior knee pain exacerbated by activities like stair climbing and exercise. Diagnostic imaging confirmed significant cartilage defects, classified as Grade 3 according to ICRS standards.

Surgical Intervention

The patient underwent arthroscopic microfracture and autologous bone marrow-derived MSCs implantation following Fulkerson osteotomy. Surgical procedures included lateral retinaculum release and tibial tubercle realignment to stabilize the patella.

Treatment Outcome

Postoperative Recovery

Post-surgery, the patient achieved full range of motion and began weight-bearing exercises. Eighteen months later, MSC implantation facilitated significant cartilage growth, improving International Knee Documentation Committee (IKDC) and Visual Analog Scale (VAS) scores.

Long-term Assessment

Two years post-MSC treatment, the patient reported no knee complaints and maintained full range of motion. MRI confirmed substantial cartilage regeneration in previously damaged areas.

Discussion

Challenges in Management

Recurrent patellar dislocations pose challenges due to high recurrence rates and associated cartilage damage. Treatment strategies like Fulkerson osteotomy combined with MSC therapy offer promising outcomes for severe cases.

Role of MSC Therapy

MSCs demonstrate potential in cartilage regeneration due to their chondrogenic differentiation capabilities and anti-inflammatory properties. This case highlights the efficacy of MSC therapy in managing extensive cartilage defects.

Conclusion

Combining Fulkerson osteotomy with MSC implantation represents a viable treatment option for chronic patellar instability and associated cartilage lesions. The integration of microfracture and MSC therapy supports significant cartilage regeneration and functional recovery.

Related Posts

Clinical Advances in Mesenchymal Stem Cell Therapy: Combating Inflammaging and Driving Systemic Rejuvenation
The Expanding Role of MSCs in Regenerative Medicine Mesenchymal stem cells (MSCs)...
Read More
Exosomes in Multiple Sclerosis Management: A Regenerative Neurology Perspective
Exploring Neuroprotection and Immune Modulation for MS Multiple sclerosis (MS) remains one...
Read More
Muse Cells: The Stress-Resistant Pluripotent Stem Cells Driving the Future of Regenerative Medicine
Unlocking Multi-Organ Regeneration and Anti-Aging Therapies In the ever-expanding field of regenerative...
Read More
Privacy Policy           Terms of Service         2025.All rights reserved.

Datran Center. 9100 S. Dadeland Boulevard, Suite 1500. Miami Fl. 33156. United States
Open chat
Have questions?
Get in contact with us...
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram